Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
aryx.com

See what CB Insights has to offer

Founded Year

1997

Stage

PIPE | IPO

Total Raised

$110.4M

About ARYX Therapeutics

ARYx Therapeutics is a privately-held pharmaceutical research and development company focused on addressing safety concerns in well-established and commercially successful existing therapies through application of its proprietary ARYx RetroMetabolic (ARM) drug design. ARYx improves today's drugs, making proven therapies safer. ARYx currently has three products in clinical trials. For more information, please see the company's web site at www.aryx.com.

ARYX Therapeutics Headquarter Location

6300 Dumbarton Circle

Fremont, California, 94555,

United States

510-585-2200

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ARYX Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ARYX Therapeutics is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

ARYX Therapeutics Patents

ARYX Therapeutics has filed 3 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/21/2007

5/31/2011

Calcium channel blockers, Piperidines, Amines, Fluoroarenes, Designer drugs

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

12/21/2007

00/00/0000

00/00/0000

Grant Date

5/31/2011

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Calcium channel blockers, Piperidines, Amines, Fluoroarenes, Designer drugs

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.